BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

BioStem Technologies (OTC: BSEM) announced management will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026 at 8:45 am ET.

Live and archived webcasts will be available on the company’s investors page at ir.biostemtechnologies.com for interested parties and investors.

News Market Reaction – BSEM

+3.16%

1 alert

+3.16% News Effect

On the day this news was published, BSEM gained 3.16%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

POMPANO BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the 25^th Annual Needham Virtual Healthcare Conference.

BioStem’s management is scheduled to present on Monday, April 13, 2026, at 8:45 am ET. Interested parties may access live and archived webcasts of the presentations on the “investors” section of the Company’s website at: ir.biostemtechnologies.com.

About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain®, CryoTek® and SteriTek® processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.

BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). BioStem’s portfolio of quality brands includes its Neox®, Clarix®, VENDAJE® and American Amnion™ product lines.

For more information, visit biostemtechnologies.com and follow us on X and LinkedIn.

Join BioStem’s Distribution List & Social Media:
To follow the latest developments at BioStem, sign up for the Company’s email distribution list HERE, and follow us on X and LinkedIn.

Contact BioStem:
Website: www.biostemtechnologies.com
E-Mail: info@biostemtech.com
X: @BSEM_Tech
Facebook: BioStemTechnologies
Phone: 954-380-8342

Investor Relations:
Philip Trip Taylor, Gilmartin
E-Mail: ir@biostemtech.com

FAQ

When will BioStem Technologies (BSEM) present at the Needham Virtual Healthcare Conference?

BioStem Technologies will present on Monday, April 13, 2026 at 8:45 am ET. According to the company, management will deliver a presentation and a webcast will be available for live viewing and later archived access on the investor website.

How can investors watch the BioStem (BSEM) presentation from April 13, 2026?

Investors can watch via live webcast or archived replay on the company investor site. According to the company, webcasts will be posted at ir.biostemtechnologies.com with both live streaming and on‑demand access after the event.

What topics will BioStem (BSEM) management cover in the April 13, 2026 presentation?

The presentation will cover company developments and strategic outlook relevant to regenerative medicine. According to the company, management will discuss the business focus on perinatal tissue allograft products and provide an update for investors during the conference session.

Is the BioStem (BSEM) Needham presentation available to the public or only to accredited investors?

The presentation is publicly accessible via webcast on the company investor site. According to the company, interested parties may access both live and archived webcasts on ir.biostemtechnologies.com without special accreditation requirements.

Where can I find the archived webcast of BioStem Technologies (BSEM) after April 13, 2026?

Archived webcasts will be posted on the company's investor relations website after the event. According to the company, the replay will be available at ir.biostemtechnologies.com for on‑demand viewing following the conference presentation.